Theranostics for COVID-19 Antiviral Drugs: Prospects and Challenges for Worldwide Precision/Personalized Medicine
OMICS: A Journal of Integrative Biology · 2023
DOI: 10.1089/omi.2022.0151 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift OMICS: A Journal of Integrative Biology, 2023. Verfasst von Caíque Manóchio und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Patologia, Genética e Evolução, Instituto de Ciências Biológicas e Naturais, Universidade Federal do Triângulo Mineiro, Uberaba, Braz…. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 73 Literaturangaben.
Abstract (Originalsprache)
Coronavirus disease 2019 (COVID-19) is a systemic disease that impacts multiple organ systems with a complex clinical presentation and outcomes that can vary from person to person and between populations. To optimize COVID-19 treatment outcomes, and in light of the availability of antiviral drugs, there is a need for greater attention to the field of theranostics, the fusion of therapeutics and diagnostics. Theranostics tests would be invaluable, we suggest in this expert review, so as to optimize the efficacy and safety of current and future antiviral drugs against COVID-19. Theranostics would also assist in the design and implementation of clinical trials with antiviral drug candidates. We discuss here theranostics considering drugs such as remdesivir, Paxlovid™, and molnupiravir. All in all, we underscore that theranostics as a concept and practice is essential for efficient and safe health interventions against COVID-19 and other ecological crises in the 21st century.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Patologia, Genética e Evolução, Instituto de Ciências Biológicas e Naturais, Universidade Federal do Triângulo Mineiro, Uberaba, Brazil.
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
ORCID-Profile: Fernanda Rodrigues-Soares
Zitieren
APA
Manóchio, C., Torres-Loureiro, S., Scudeler, M. M., Miwa, B., Souza-Santos, F. C., & Rodrigues-Soares, F. (2023). Theranostics for COVID-19 Antiviral Drugs: Prospects and Challenges for Worldwide Precision/Personalized Medicine. OMICS: A Journal of Integrative Biology. https://doi.org/10.1089/omi.2022.0151
Vancouver
Manóchio C, Torres-Loureiro S, Scudeler MM, Miwa B, Souza-Santos FC, Rodrigues-Soares F. Theranostics for COVID-19 Antiviral Drugs: Prospects and Challenges for Worldwide Precision/Personalized Medicine. OMICS: A Journal of Integrative Biology. 2023. doi:10.1089/omi.2022.0151
BibTeX
@article{Manchio2023,
author = {Manóchio, Caíque and Torres-Loureiro, Sabrina and Scudeler, Mariana M and Miwa, Bruno and Souza-Santos, Fernanda C and Rodrigues-Soares, Fernanda},
title = {Theranostics for COVID-19 Antiviral Drugs: Prospects and Challenges for Worldwide Precision/Personalized Medicine},
journal = {OMICS: A Journal of Integrative Biology},
year = {2023},
doi = {10.1089/omi.2022.0151}
}
EUVIMED